Increased risk of proximal colon cancer among A-bomb survivors based on CHEK2 gene polymorphism and radiation dose

被引：0
|
作者：
Hayashi, Tomonori [1 ]
Ohishi, Waka [2 ]
Kyoizumi, Seishi [1 ]
机构：
[1] Rad Effects Res Found, Dept Mol Biosci, Hiroshima, Japan
[2] Rad Effects Res Found, Dept Clin Studies, Hiroshima, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
CHK2; colon cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2394
引用
收藏
页码：771 / 771
页数：1
相关论文
共 50 条
  • [31] Breast cancer screening implications of risk modeling among female relatives of ATM and CHEK2 carriers
    Weidner, Anne E.
    Liggin, Mariel E.
    Zuniga, Brenda I.
    Tezak, Ann L.
    Wiesner, Georgia L.
    Pal, Tuya
    CANCER, 2020, 126 (08) : 1651 - 1655
  • [32] STUDIES OF CANCER AND RADIATION-DOSE AMONG ATOMIC-BOMB SURVIVORS - THE EXAMPLE OF BREAST-CANCER
    LAND, CE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (05): : 402 - 407
  • [33] Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation
    Carmichael, A
    Sami, AS
    Dixon, JM
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (05): : 475 - 479
  • [34] Differences in cancer prevalence among CHEK2 carriers identified via multi-gene panel testing
    Sutcliffe, Erin G.
    Stettner, Amy R.
    Miller, Stacey A.
    Solomon, Sheila R.
    Marshall, Megan L.
    Roberts, Maegan E.
    Susswein, Lisa R.
    Arvai, Kevin J.
    Klein, Rachel T.
    Murphy, Patricia D.
    Hruska, Kathleen S.
    CANCER GENETICS, 2020, 246 : 12 - 17
  • [35] Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study
    L Mellemkjær
    C Dahl
    J H Olsen
    L Bertelsen
    P Guldberg
    J Christensen
    A-L Børresen-Dale
    M Stovall
    B Langholz
    L Bernstein
    C F Lynch
    K E Malone
    R W Haile
    M Andersson
    D C Thomas
    P Concannon
    M Capanu
    J D Boice
    J L Bernstein
    British Journal of Cancer, 2008, 98 : 728 - 733
  • [36] CHEK2 gene analysis in 1020 high-risk breast and ovarian cancer patients in the Czech Republic
    Stolarova, L.
    Kleiblova, P.
    Zemankova, P.
    Janatova, M.
    Borecka, M.
    Zdarilova, K.
    Sevcik, J.
    Soukupova, J.
    Kleibl, Z.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S27 - S27
  • [37] ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
    Stolarova, Lenka
    Kleiblova, Petra
    Zemankova, Petra
    Stastna, Barbora
    Janatova, Marketa
    Soukupova, Jana
    Achatz, Maria Isabel
    Ambrosone, Christine
    Apostolou, Paraskevi
    Arun, Banu K.
    Auer, Paul
    Barnard, Mollie
    Bertelsen, Birgitte
    Japan, Biobank
    Blok, Marinus J.
    Boddicker, Nicholas
    Brunet, Joan
    Burnside, Elizabeth S.
    Calvello, Mariarosaria
    Campbell, Ian
    Chan, Sock Hoai
    Chen, Fei
    Chiang, Jian Bang
    Coppa, Anna
    Cortesi, Laura
    Crujeiras-Gonzalez, Ana
    Czecanca, Consortium
    De Leeneer, Kim
    De Putter, Robin
    DePersia, Allison
    Devereux, Lisa
    Domchek, Susan
    Efremidis, Anna
    Engel, Christoph
    Ernst, Corinna
    Evans, D. Gareth R.
    Feliubadalo, Lidia
    Fostira, Florentia
    Fuentes-Rios, Olivia
    Gomez-Garcia, Encarna B.
    Gonzalez, Sara
    Haiman, Christopher
    Hansen, Thomas van Overeem
    Hauke, Jan
    Hodge, James
    Hu, Chunling
    Huang, Hongyan
    Ishak, Nur Diana Binte
    Iwasaki, Yusuke
    Konstantopoulou, Irene
    CLINICAL CANCER RESEARCH, 2023, 29 (16) : 3037 - 3050
  • [38] Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study
    Mellemkjaer, L.
    Dahl, C.
    Olsen, J. H.
    Bertelsen, L.
    Guldberg, P.
    Christensen, J.
    Borresen-Dale, A-L
    Stovall, M.
    Langholz, B.
    Bernstein, L.
    Lynch, C. F.
    Malone, K. E.
    Haile, R. W.
    Andersson, M.
    Thomas, D. C.
    Concannon, P.
    Capanu, M.
    Boice, J. D., Jr.
    Bernstein, J. L.
    BRITISH JOURNAL OF CANCER, 2008, 98 (04) : 728 - 733
  • [39] Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers
    Cragun, Deborah
    Weidner, Anne
    Tezak, Ann
    Clouse, Kate
    Pal, Tuya
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (02) : 421 - 428
  • [40] Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers
    Deborah Cragun
    Anne Weidner
    Ann Tezak
    Kate Clouse
    Tuya Pal
    Breast Cancer Research and Treatment, 2020, 182 : 421 - 428
12345